Effect of Mat Pilates Training on Women After Menopause

Physical Activity Clinical Trial

Official title:

Effect of Mat Pilates Training on Climacteric Symptoms and Physiological Changes in Women After Menopause

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03626792
• Other study ID #: 68408116.9.0000.5152
• Status: Completed
• Phase: N/A
• Start date: August 5, 2017
• Est. completion date: March 28, 2018

Study information

• Verified date: March 2022
• Source: Federal University of Uberlandia
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This project aims to verify the chronic effect of Mat Pilates exercise on climacteric symptoms, ambulatory blood pressure responses, lipid and glucose profile and pro and anti-inflammatory and antioxidant markers in postmenopausal normotensive and hypertensive women. All volunteers received the same intervention.

Description:

The Pilates program was performed three times a week for 12 weeks. Initially a familiarization was made regarding the principles of the method. All volunteers underwent 24-hour blood pressure assessment using ambulatory blood pressure measurement (ABPM) and venous blood samples were collected from fasting, saliva and questionnaires before and after the Pilates training period.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: March 28, 2018
• Est. primary completion date: December 20, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 40 Years to 70 Years

Eligibility

Inclusion Criteria:

• Women between the ages of 40 and 70;

• Be post menopausal (amenorrhea for at least 12 months);

• Medical release to perform physical activities.

• Do not present physical problems or cardiovascular complications that prevent the performance of physical exercises;

Exclusion Criteria:

• To present a history of stroke or acute myocardial infarction;

• Smoking;

• Diagnosis of Diabetes Mellitus.

• Present renal pathologies.

• Use medications that interfere with lipid metabolism;

• Use of antihypertensive drugs (except for the hypertensive group);

• Use hormone replacement therapies;

• Present gastrointestinal conditions.

Related Conditions & MeSH terms

• Blood Pressure
• Physical Activity

Intervention

Other:
• Hypertensive group
Pilates 12-week training on the ground, often 3 times a week for 50 minutes of prescribed method exercises.
• Normotensive group
Pilates 12-week training on the ground, often 3 times a week for 50 minutes of prescribed method exercises.

Locations

Country	Name	City	State
Brazil	Jaqueline Pontes Batista	Uberlândia	Minas Gerais

Sponsors (1)

Lead Sponsor	Collaborator
Federal University of Uberlandia

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Biochemical analyzes	From the serum and/or plasma and saliva samples collected and stored, analyzes for lipid profile (total cholesterol and fractions, and triglycerides) and glycemia at rest and for the concentrations of inflammatory cytokines and changes in the activity of the Antioxidant system.	Change from Baseline at 12 weeks
Primary	Blood pressure	Resting diastolic and systolic blood pressures will be monitored by Microlife® BP 3BT0A automatic monitor in mmHg.	Change from Baseline at 12 weeks
Secondary	Ambulatory blood pressure monitoring	Ambulatory blood pressure monitoring will be monitored during 24 hours using a Dyna+ ABPM device in mmHg.	Change from Baseline at 12 weeks
Secondary	Kupperman - Blatt Index	The climacteric symptoms will be evaluated by the following questionnaire Kupperman - Blatt Index. The questionnaire has scores that from 0 to 19 indicate mild symptoms, 20 to 35 moderate and greater than 35 symptoms of severe climacteric.	Change from Baseline at 12 weeks
Secondary	Cervical Scale	The climacteric symptoms will be evaluated by the following questionnaire Cervical Scale. The questionnaire does not have scales. Indicates only a high or low score regarding the presence of climacteric symptoms.	Change from Baseline at 12 weeks
Secondary	Menopause Rating Scale (MRS)	The climacteric symptoms will be evaluated by the following questionnaire Menopause Rating Scale (MRS). The scores from 0 to 4 of the questionnaire indicate absence of symptoms, as well as from 5 to 8 presence of mild symptoms, 9 to 15 moderate and greater than 16 symptoms of severe climacteric.	Change from Baseline at 12 weeks
Secondary	Sleep quality	Sleep quality will be assessed by the Pittsburgh Sleep Quality Index (PSQI).A score of 0 to 4 indicates a good quality of sleep, 5 to 10 quality of bad sleep and greater than 10 the presence of sleep disorder.	Change from Baseline at 12 weeks